Yanik, G. A., Naranjo, A., Parisi, M. T., Shulkin, B. L., Nadel, H. R., Gelfand, M. J., … Matthay, K. K. (2014). Validation of postinduction Curie scores in high-risk neuroblastoma. In Journal of Clinical Oncology (Vol. 32, pp. 10031–10031). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2014.32.15_suppl.10031

Yanik, Gregory A., Arlene Naranjo, Marguerite T. Parisi, Barry L. Shulkin, Helen R. Nadel, Michael J. Gelfand, Ruth L. Ladenstein, et al. “Validation of postinduction Curie scores in high-risk neuroblastoma.” In Journal of Clinical Oncology, 32:10031–10031. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.15_suppl.10031.

Yanik GA, Naranjo A, Parisi MT, Shulkin BL, Nadel HR, Gelfand MJ, et al. Validation of postinduction Curie scores in high-risk neuroblastoma. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 10031–10031.

Yanik, Gregory A., et al. “Validation of postinduction Curie scores in high-risk neuroblastoma.” Journal of Clinical Oncology, vol. 32, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2014, pp. 10031–10031. Crossref, doi:10.1200/jco.2014.32.15_suppl.10031.

Yanik GA, Naranjo A, Parisi MT, Shulkin BL, Nadel HR, Gelfand MJ, Ladenstein RL, Boubaker A, Poetschger U, Lambert B, Castellani MR, Valteau-Couanet D, Kreissman SG, Park JR, Matthay KK. Validation of postinduction Curie scores in high-risk neuroblastoma. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 10031–10031.